House drug pricing bill coming in September

House Democrats plan to release their drug pricing bill in September, The Hill reports.

Advertisement

An aide of House Speaker Nancy Pelosi, D-Calif., told The Hill the plan will include provisions to authorize direct negotiation between Medicare and drug companies. It would also apply Medicare-negotiated rates to private payers. The bill includes a provision to tax pharmaceutical companies if price negotiations stall, according to the report.  

Democrats are waiting to release the bill until after Congress’ upcoming recess, so pharmaceutical companies do not have an opening to pick apart the bill, according to the report.

Read the full story here.

 

More articles on leadership and management:

California health system to lay off 43 employees
4 Democratic presidential candidates back Kaiser workers in strike
Seema Verma is ‘deeply concerned’ about ‘Medicare for All,’ public option

At Becker's 4th Annual CEO + CFO Roundtable, taking place November 2–5 in Chicago, more than 1,500 hospital and health system executives tackle decisions that determine whether organizations thrive or merely survive: protecting margins under cost pressure, choosing where to grow, renegotiating payer relationships, stabilizing the workforce and proving real ROI on technology. This is where leaders work through them together, face-to-face. Apply for complimentary registration now.

Register to Attend Webinar

From fragmentation to operational flow: Solving the healthcare workforce puzzle

Tuesday, August 11
1:00 PM - 2:00 PM CDT

Presenters: Dr. Pat Hunt, QGendaAndrea Daugherty, MHA, CISSP, CHCIO, CDH-E, Arrowhead Regional Medical CenterElizabeth Lindsay-Wood, MBA, CHCIO, CDH-E, Moffitt Cancer CenterDeb Muro, El Camino HealthJohn Tejeda, D.H.A., MLS, MPAS, DFAAPA, LSSBB, FACHE, Vascular and Neuroscience Institute

Advertisement

Next Up in Leadership & Management

Advertisement

Comments are closed.